A Scalable and Efficient Bioprocess for Manufacturing Human Pluripotent Stem Cell-Derived Endothelial Cells.
Stem Cell Reports
; 11(2): 454-469, 2018 08 14.
Article
em En
| MEDLINE
| ID: mdl-30078557
ABSTRACT
Endothelial cells (ECs) are of great value for cell therapy, tissue engineering, and drug discovery. Obtaining high-quantity and -quality ECs remains very challenging. Here, we report a method for the scalable manufacturing of ECs from human pluripotent stem cells (hPSCs). hPSCs are expanded and differentiated into ECs in a 3D thermoreversible PNIPAAm-PEG hydrogel. The hydrogel protects cells from hydrodynamic stresses in the culture vessel and prevents cells from excessive agglomeration, leading to high-culture efficiency including high-viability (>90%), high-purity (>80%), and high-volumetric yield (2.0 × 107 cells/mL). These ECs (i.e., 3D-ECs) had similar properties as ECs made using 2D culture systems (i.e., 2D-ECs). Genome-wide gene expression analysis showed that 3D-ECs had higher expression of genes related to vasculature development, extracellular matrix, and glycolysis, while 2D-ECs had higher expression of genes related to cell proliferation.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Reatores Biológicos
/
Células-Tronco Pluripotentes
/
Células Endoteliais
/
Técnicas de Cultura Celular por Lotes
Limite:
Humans
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article